Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Prostatic Neoplasms × sulforaphane × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostate Cancer Prevention 1 Leukemia, Myeloid, Acute 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Radiosurgery 40 Magnetic Resonance Spectroscopy 34 Radiotherapy 25 Exercise 25 Standard of Care 24 Brachytherapy 20 Early Intervention, Educational 18 Magnetic Resonance Imaging 15 Surveys and Questionnaires 14 Androgen Antagonists 14 Interviews as Topic 13 Blood Specimen Collection 13 Psychiatric Rehabilitation 11 Multiparametric Magnetic Resonance Imaging 11 Methods 11 Biopsy 11 Therapeutics 10 Specimen Handling 10 Radiotherapy, Intensity-Modulated 10 Educational Status 10 Prostatectomy 9 Resistance Training 8 Radiation 7 Practice Guidelines as Topic 7 Diet Therapy 7 Acupuncture Therapy 7 gallium 68 PSMA-11 6 bicalutamide 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Proton Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04046653 2020-11-18

ADaPT

Quadram Institute Bioscience

Phase NA Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡